Steady-State Concentrations of Mirtazapine, N-Desmethylmirtazapine, 8-Hydroxymirtazapine and their Enantiomers in Relation to Cytochrome P450 2D6 Genotype, Age and Smoking Behaviour
- 1 January 2009
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 48 (1) , 63-70
Abstract
Background and objective Mirtazapine is a tetracyclic antidepressant drug available as a racemic mixture of S(+)- and R(−)-mirtazapine. These enantiomers have different pharmacological properties,...Keywords
This publication has 30 references indexed in Scilit:
- Therapeutic Drug Monitoring of Mirtazapine, Desmethylmirtazapine, 8-Hydroxymirtazapine, and Mirtazapine-N-oxide by Enantioselective HPLC With Fluorescence DetectionTherapeutic Drug Monitoring, 2006
- Mirtazapine naturalistic depression study (in Sweden)—MINDS(S): clinical efficacy and safetyHuman Psychopharmacology: Clinical and Experimental, 2006
- Mirtazapine Enantiomers in Blood and Cerebrospinal FluidNeuropsychobiology, 2006
- Inter- and Intraindividual Pharmacokinetic Variations of Mirtazapine and Its N-Demethyl Metabolite in Patients Treated for Major Depressive DisorderTherapeutic Drug Monitoring, 2005
- Cytochrome P450 Phenotyping/Genotyping in Patients Receiving AntipsychoticsClinical Pharmacokinetics, 2002
- Clinical Pharmacokinetics of MirtazapineClinical Pharmacokinetics, 2000
- Ultrarapid metabolizers of debrisoquine: Characterization and PCR‐based detection of alleles with duplication of the CYP2D6 geneFEBS Letters, 1996
- Pharmacokinetic dose-proportionality study at steady state of mirtazapine from Remeron® tabletsHuman Psychopharmacology: Clinical and Experimental, 1995
- Dextromethorphan and Mephenytoin Phenotyping of Patients Treated with Thioridazine or AmitriptylineTherapeutic Drug Monitoring, 1992
- In vitro studies of induction and inhibition of drug oxidation in manPharmacology & Therapeutics, 1987